Axsome Therapeutics (AXSM) Q4 2024 Earnings Report
MX:AXSM Q4 2024 EPS Results
- Actual EPS
- -MXN 28.61
- Consensus EPS
- -MXN 18.60
- Beat/Miss
- Missed by -MXN 10.02
- One Year Ago EPS
- -MXN 38.65
MX:AXSM Q4 2024 Revenue Results
- Actual Revenue
- MXN 2.21B
- Expected Revenue
- MXN 2.19B
- Beat/Miss
- Beat by +MXN 12.95M
- YoY Revenue Growth
- +66.03%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/18/2025
- Time
- Before Open
- Conference Call
- Tuesday, February 18, 2025
MX:AXSM Upcoming Earnings
Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
MX:AXSM Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:AXSM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.69- | -10.41 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -11.78-4.65 | -17.47 | 73.40% (+12.82) | |
| Aug 10, 2026 | 2026 (Q2) | -16.57-18.39 | -18.02 | -2.06% (-0.37) | |
| May 04, 2026 | 2026 (Q1) | -15.68-23.41 | -22.67 | -3.28% (-0.74) | |
| Feb 23, 2026 | 2025 (Q4) | -12.90-10.41 | -28.61 | 63.64% (+18.21) | |
| Nov 03, 2025 | 2025 (Q3) | -16.00-17.47 | -24.9 | 29.85% (+7.43) | |
| Aug 04, 2025 | 2025 (Q2) | -19.60-18.02 | -31.03 | 41.92% (+13.01) | |
| May 05, 2025 | 2025 (Q1) | -25.10-22.67 | -26.76 | 15.28% (+4.09) | |
| Feb 18, 2025 | 2024 (Q4) | -18.60-28.61 | -38.65 | 25.96% (+10.03) | |
| Nov 12, 2024 | 2024 (Q3) | -25.70-24.90 | -24.53 | -1.52% (-0.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
